PMID- 15892717 OWN - NLM STAT- MEDLINE DCOM- 20050928 LR - 20161021 IS - 0893-5785 (Print) IS - 0893-5785 (Linking) VI - 18 IP - 3 DP - 2005 Jun TI - Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. PG - 203-13 AB - Senescent cells are known to display altered gene expression of differentiation-associated genes. We have previously demonstrated that the melanocyte transcriptional regulator microphthalmia-associated protein (MITF) is down-regulated in senescent melanocytes. Since virtually nothing is known regarding the differentiated function of senescent melanocytes, we analyzed the transcriptional regulation of Dopachrome tautomerase (DCT), a member of the tyrosinase gene family, in proliferating and in senescent human melanocytes. Computational analysis of the region containing the M-box that includes the MITF CATGTG binding motif demonstrated that this sequence overlaps with the estrogen receptor alpha (ER-alpha), USF-1, TFE-3, Isl-1 and AP-1 binding elements. Electrophoresis gel-shift analysis using an oligonucleotide containing MITF and ERE elements identified MITF and ER-alpha complexes in proliferating melanocytes, whereas only ER-alpha complexes were detected in senescent cells. Importantly, a promoter-reporter analysis demonstrated that the coactivator p300/CBP switched MITF from a repressor to an activator of DCT transcription. p300/CBP was also required by ER-alpha and MITF to induce high, synergistic activation of the DCT promoter. We have also found that transcription of the DCT gene is differentially regulated by major melanocyte mitogens. In contrast to the activating effect of cAMP inducers, 12-O-tetradecanoylphorbolacetate (TPA) was a potent repressor of DCT transcription, suggesting that this gene can be differentially regulated by multiple environmental signals and promoter context. In support of this conclusion, trichostatin A, a histone deacetylase inhibitor, counteracted the TPA-mediated repression, and restored high levels of DCT protein in cultured melanocytes. We conclude that senescent melanocytes display dramatic changes in the expression of differentiation-related proteins; such changes may in turn result in altered melanocyte function and survival to environmental stresses. FAU - Schwahn, Denise J AU - Schwahn DJ AD - Departmentsof Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. FAU - Timchenko, Nikolai A AU - Timchenko NA FAU - Shibahara, Shigeki AU - Shibahara S FAU - Medrano, Estela E AU - Medrano EE LA - eng GR - 1P01 AG19254/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. PL - Denmark TA - Pigment Cell Res JT - Pigment cell research JID - 8800247 RN - 0 (Chromatin) RN - 0 (DNA-Binding Proteins) RN - 0 (Enzyme Inhibitors) RN - 0 (Estrogen Receptor alpha) RN - 0 (MITF protein, human) RN - 0 (Microphthalmia-Associated Transcription Factor) RN - 0 (Transcription Factors) RN - EC 5.3.- (Intramolecular Oxidoreductases) RN - EC 5.3.3.12 (dopachrome isomerase) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Cell Proliferation/drug effects MH - Chromatin/*metabolism MH - DNA-Binding Proteins/*metabolism MH - Enzyme Inhibitors/pharmacology MH - Estrogen Receptor alpha/*metabolism MH - Gene Expression Regulation, Enzymologic/drug effects MH - Humans MH - Intramolecular Oxidoreductases/antagonists & inhibitors/*genetics/metabolism MH - Melanocytes/cytology/drug effects/*metabolism MH - Microphthalmia-Associated Transcription Factor MH - Promoter Regions, Genetic/drug effects/genetics/*physiology MH - Tetradecanoylphorbol Acetate/pharmacology MH - Transcription Factors/*metabolism EDAT- 2005/05/17 09:00 MHDA- 2005/09/29 09:00 CRDT- 2005/05/17 09:00 PHST- 2005/05/17 09:00 [pubmed] PHST- 2005/09/29 09:00 [medline] PHST- 2005/05/17 09:00 [entrez] AID - PCR229 [pii] AID - 10.1111/j.1600-0749.2005.00229.x [doi] PST - ppublish SO - Pigment Cell Res. 2005 Jun;18(3):203-13. doi: 10.1111/j.1600-0749.2005.00229.x.